These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31146657)

  • 1. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding.
    Ramírez-Orozco RE; García-Ruiz R; Morales P; Villalón CM; Villafán-Bernal JR; Marichal-Cancino BA
    Curr Neuropharmacol; 2019; 17(10):947-960. PubMed ID: 31146657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55.
    Guerrero-Alba R; Barragán-Iglesias P; González-Hernández A; Valdez-Moráles EE; Granados-Soto V; Condés-Lara M; Rodríguez MG; Marichal-Cancino BA
    Front Pharmacol; 2018; 9():1496. PubMed ID: 30670965
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.
    Irving A; Abdulrazzaq G; Chan SLF; Penman J; Harvey J; Alexander SPH
    Adv Pharmacol; 2017; 80():223-247. PubMed ID: 28826536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction.
    Rajaraman G; Simcocks A; Hryciw DH; Hutchinson DS; McAinch AJ
    Mol Nutr Food Res; 2016 Jan; 60(1):92-102. PubMed ID: 26337420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors.
    Gasperi V; Dainese E; Oddi S; Sabatucci A; Maccarrone M
    Curr Med Chem; 2013; 20(1):64-78. PubMed ID: 23151004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential role for GPR55 in gastrointestinal functions.
    Schicho R; Storr M
    Curr Opin Pharmacol; 2012 Dec; 12(6):653-8. PubMed ID: 23063456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological tools in endocannabinoid neurobiology.
    Mor M; Lodola A
    Curr Top Behav Neurosci; 2009; 1():87-110. PubMed ID: 21104381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cannabinoid receptors.
    Brown AJ
    Br J Pharmacol; 2007 Nov; 152(5):567-75. PubMed ID: 17906678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.
    Malek N; Popiolek-Barczyk K; Mika J; Przewlocka B; Starowicz K
    Neural Plast; 2015; 2015():130639. PubMed ID: 26090232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
    Zou S; Kumar U
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Hu G; Ren G; Shi Y
    Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthetic cannabinoids menace: a review of health risks and toxicity.
    Alzu'bi A; Almahasneh F; Khasawneh R; Abu-El-Rub E; Baker WB; Al-Zoubi RM
    Eur J Med Res; 2024 Jan; 29(1):49. PubMed ID: 38216984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-Binding Receptors as Drug Targets.
    Gómez-Cañas M; Rodríguez-Cueto C; Satta V; Hernández-Fisac I; Navarro E; Fernández-Ruiz J
    Methods Mol Biol; 2023; 2576():67-94. PubMed ID: 36152178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature.
    MacIntyre J; Dong A; Straiker A; Zhu J; Howlett SE; Bagher A; Denovan-Wright E; Yu DY; Kelly ME
    Eur J Pharmacol; 2014 Jul; 735():105-14. PubMed ID: 24751709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide.
    Im DS
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of the Cannabinoid Receptor Family in Peripheral and Neuro-immune Interactions.
    Haugh O; Penman J; Irving AJ; Campbell VA
    Curr Drug Targets; 2016; 17(16):1834-1840. PubMed ID: 26758668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.